Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection – November 27, 2023 at 01:01 AM ET
The Elecsys® HBeAg Quantification is an immunoassay that can be used as an early marker of acute hepatitis B infection or as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information. A single test will inform clinicians whether treatment … Read more